<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40969290</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2272</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Pediatric investigation</Title><ISOAbbreviation>Pediatr Investig</ISOAbbreviation></Journal><ArticleTitle>Low-dose versus high-dose methylprednisolone for children with severe <i>Mycoplasma pneumoniae</i> pneumonia (MCMP): A randomized controlled trial.</ArticleTitle><Pagination><StartPage>251</StartPage><EndPage>261</EndPage><MedlinePgn>251-261</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ped4.70014</ELocationID><Abstract><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Although macrolides combined with glucocorticoid therapy have demonstrated efficacy in preventing long-term pulmonary lesions of severe <i>Mycoplasma pneumoniae</i> pneumonia (MPP), evidence regarding glucocorticoid dose is lacking.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To evaluate the effects of low- and high-dose methylprednisolone on the risk of long-term pulmonary lesions for children with severe MPP when combined with azithromycin.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This randomized, parallel-controlled, multicenter clinical trial was conducted in mainland China and enrolled pediatric patients hospitalized with severe MPP. A total of 424 enrolled patients were randomized (allocation ratio of 1:1) to azithromycin combined with either a low-dose [2 mg/(kg&#xb7;d)] or a high-dose [10 mg/(kg&#xb7;d)] methylprednisolone treatment for 3 d followed by tapering over 12 d. The primary outcome was the incidence of composite adverse outcomes, including atelectasis, bronchiectasis, or bronchiolitis obliterans 6 months after treatment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 118 (27.8%) developed adverse pulmonary lesions at 6 months after treatment; 66 of 211 (31.3%) in the high-dose methylprednisolone group and 52 of 213 (24.4%) in the low-dose group, respectively. The risk ratio of long-term pulmonary lesions in a high-dose group to those in a low-dose group was 1.28 (95% confidence interval [95% CI]: 0.94-1.75). In addition, the risk of hypertension in the high-dose group (8.1%, 17 of 211) was higher than that in the low-dose group (1.4%, three of 213), with a risk ratio of 5.72 (95% CI: 1.70-19.23).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Azithromycin combined with low-dose methylprednisolone demonstrates non-inferior efficacy in reducing pulmonary lesions at 6-month follow-up compared to combined with high-dose methylprednisolone while exhibiting a more favorable safety profile.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Pediatric Investigation published by John Wiley &amp; Sons Australia, Ltd on behalf of Futang Research Center of Pediatric Development.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Baoping</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7157-8078</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Disease Beijing Children's Hospital, Capital Medical University China National Clinical Research Center of Respiratory Diseases National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Respiratory Disease Capital Center for Children's Health Capital Medical University Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Yunxiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatric Shengjing Hospital of China Medical University Liaoning China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Liping</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Respiratory department Shanxi Children's Hospital Shanxi China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Liwei</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7652-7456</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Disease Beijing Children's Hospital, Capital Medical University China National Clinical Research Center of Respiratory Diseases National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Ju</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory Disease Beijing Children's Hospital, Capital Medical University China National Clinical Research Center of Respiratory Diseases National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory Disease Beijing Children's Hospital, Capital Medical University China National Clinical Research Center of Respiratory Diseases National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Ruohua</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Center for Clinical Epidemiology &amp; Evidence-based Medicine Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Respiratory Disease Capital Center for Children's Health Capital Medical University Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatric Shengjing Hospital of China Medical University Liaoning China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Zhiying</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Respiratory department Shanxi Children's Hospital Shanxi China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5745-2310</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Disease Beijing Children's Hospital, Capital Medical University China National Clinical Research Center of Respiratory Diseases National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Wenhui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Respiratory Disease Capital Center for Children's Health Capital Medical University Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatric Shengjing Hospital of China Medical University Liaoning China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Respiratory department Shanxi Children's Hospital Shanxi China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yiqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Respiratory Department, Baoding Hospital of Beijing Children's Hospital Capital Medical University Hebei China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hao</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9932-5339</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Disease Beijing Children's Hospital, Capital Medical University China National Clinical Research Center of Respiratory Diseases National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xirong</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-7002-4305</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Disease Beijing Children's Hospital, Capital Medical University China National Clinical Research Center of Respiratory Diseases National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory Disease Capital Center for Children's Health Capital Medical University Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatric Shengjing Hospital of China Medical University Liaoning China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaojuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Respiratory department Shanxi Children's Hospital Shanxi China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>He</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Respiratory Department, Baoding Hospital of Beijing Children's Hospital Capital Medical University Hebei China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Anxia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Interventional Pulmonology Beijing Children's Hospital, Capital Medical University China National Clinical Research Center of Respiratory Diseases National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Adong</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Pediatric Respiratory Infection Diseases Beijing Pediatric Research Institute Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Keqing</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>John S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Vanke School of Public Health Tsinghua University Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xiaoxia</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-8789-469X</Identifier><AffiliationInfo><Affiliation>Department of Center for Clinical Epidemiology &amp; Evidence-based Medicine Beijing Children's Hospital, Capital Medical University National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Kunling</ForeName><Initials>K</Initials><Identifier Source="ORCID">0009-0001-0045-6468</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Disease Beijing Children's Hospital, Capital Medical University China National Clinical Research Center of Respiratory Diseases National Center for Children's Health Beijing China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>MCMP study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Investig</MedlineTA><NlmUniqueID>101731527</NlmUniqueID><ISSNLinking>2574-2272</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Glucocorticoids</Keyword><Keyword MajorTopicYN="N">Long&#x2010;term pulmonary lesions</Keyword><Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword><Keyword MajorTopicYN="N">Pneumonia</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>19</Day><Hour>4</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40969290</ArticleId><ArticleId IdType="pmc">PMC12442439</ArticleId><ArticleId IdType="doi">10.1002/ped4.70014</ArticleId><ArticleId IdType="pii">PED470014</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et&#xa0;al. Community&#x2010;acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835&#x2010;845. DOI: 10.1056/NEJMoa1405870</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1405870</ArticleId><ArticleId IdType="pmc">PMC4697461</ArticleId><ArticleId IdType="pubmed">25714161</ArticleId></ArticleIdList></Reference><Reference><Citation>
Lee E, Kim CH, Lee YJ, Kim HB, Kim BS, Kim HY, et&#xa0;al. Annual and seasonal patterns in etiologies of pediatric community&#x2010;acquired pneumonia due to respiratory viruses and <i>Mycoplasma pneumoniae</i> requiring hospitalization in South Korea. BMC Infect Dis.
2020;20:132. DOI: 10.1186/s12879-020-4810-9

</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-4810-9</ArticleId><ArticleId IdType="pmc">PMC7017508</ArticleId><ArticleId IdType="pubmed">32050912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma H, Sun L, Wu X, Li Y, Guo Y, Li Q, et&#xa0;al. The etiology of community&#x2010;acquired pneumonia in hospitalized children of single center in Beijing (In Chinese). Chin J Evid&#x2010;Based Pediatr. 2015;10:361&#x2010;365. DOI: 10.3969/j.issn.1673-5501.2015.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.3969/j.issn.1673-5501.2015.05.008</ArticleId></ArticleIdList></Reference><Reference><Citation>
Gao LW, Yin J, Hu YH, Liu XY, Feng XL, He JX, et&#xa0;al. The epidemiology of paediatric <i>Mycoplasma pneumoniae</i> pneumonia in North China: 2006 to 2016. Epidemiol Infect.
2019;147:e192. DOI: 10.1017/S0950268819000839

</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268819000839</ArticleId><ArticleId IdType="pmc">PMC6518602</ArticleId><ArticleId IdType="pubmed">31364532</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kutty PK, Jain S, Taylor TH, Bramley AM, Diaz MH, Ampofo K, et&#xa0;al. 
<i>Mycoplasma pneumoniae</i> among children hospitalized with community&#x2010;acquired pneumonia. Clin Infect Dis.
2019;68:5&#x2010;12. DOI: 10.1093/cid/ciy419

</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy419</ArticleId><ArticleId IdType="pmc">PMC6552676</ArticleId><ArticleId IdType="pubmed">29788037</ArticleId></ArticleIdList></Reference><Reference><Citation>
Khoury T, Sviri S, Rmeileh AA, Nubani A, Abutbul A, Hoss S, et&#xa0;al. Increased rates of intensive care unit admission in patients with <i>Mycoplasma pneumoniae</i>: a retrospective study. Clin Microbiol Infect.
2016;22:711&#x2010;714. DOI: 10.1016/j.cmi.2016.05.028

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2016.05.028</ArticleId><ArticleId IdType="pubmed">27297319</ArticleId></ArticleIdList></Reference><Reference><Citation>
Lee KL, Lee CM, Yang TL, Yen TY, Chang LY, Chen JM, et&#xa0;al. Severe <i>Mycoplasma pneumoniae</i> pneumonia requiring intensive care in children, 2010&#x2010;2019. J Formos Med Assoc.
2021;120:281&#x2010;291. DOI: 10.1016/j.jfma.2020.08.018

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2020.08.018</ArticleId><ArticleId IdType="pubmed">32948415</ArticleId></ArticleIdList></Reference><Reference><Citation>
Zhou Y, Shan Y, Cui Y, Shi J, Wang F, Miao H, et&#xa0;al. Characteristics and outcome of severe <i>Mycoplasma pneumoniae</i> pneumonia admitted to PICU in Shanghai: a retrospective cohort study. Crit Care Explor.
2021;3:e0366. DOI: 10.1097/CCE.0000000000000366

</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000366</ArticleId><ArticleId IdType="pmc">PMC7994047</ArticleId><ArticleId IdType="pubmed">33786442</ArticleId></ArticleIdList></Reference><Reference><Citation>
Meyer Sauteur PM, Beeton ML. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC), and the ESGMAC <i>Mycoplasma pneumoniae</i> Surveillance (MAPS) study group. <i>Mycoplasma pneumoniae</i>: delayed re&#x2010;emergence after COVID&#x2010;19 pandemic restrictions. Lancet Microbe.
2024;5:e100&#x2010;e101. DOI: 10.1016/S2666-5247(23)00344-0

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00344-0</ArticleId><ArticleId IdType="pubmed">38008103</ArticleId></ArticleIdList></Reference><Reference><Citation>
Meyer Sauteur PM, Beeton ML; ESGMAC the ESGMAC MAPS study group
. <i>Mycoplasma pneumoniae</i>: gone forever?
Lancet Microbe.
2023;4:e763. DOI: 10.1016/S2666-5247(23)00182-9

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00182-9</ArticleId><ArticleId IdType="pubmed">37393927</ArticleId></ArticleIdList></Reference><Reference><Citation>
Meyer Sauteur PM, Chalker VJ, Berger C, Nir&#x2010;Paz R, Beeton ML, ESGMAC and the ESGMAC&#x2013;MyCOVID study group
, et&#xa0;al. 
<i>Mycoplasma pneumoniae</i> beyond the COVID&#x2010;19 pandemic: where is it?
Lancet Microbe.
2022;3:e897. DOI: 10.1016/S2666-5247(22)00190-2

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(22)00190-2</ArticleId><ArticleId IdType="pmc">PMC9371584</ArticleId><ArticleId IdType="pubmed">35964636</ArticleId></ArticleIdList></Reference><Reference><Citation>
Waites KB, Balish MF, Atkinson TP. New insights into the pathogenesis and detection of <i>Mycoplasma pneumoniae</i> infections. Future Microbiol.
2008;3:635&#x2010;648. DOI: 10.2217/17460913.3.6.635

</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/17460913.3.6.635</ArticleId><ArticleId IdType="pmc">PMC2633477</ArticleId><ArticleId IdType="pubmed">19072181</ArticleId></ArticleIdList></Reference><Reference><Citation>
He J, Liu M, Ye Z, Tan T, Liu X, You X, et&#xa0;al. Insights into the pathogenesis of <i>Mycoplasma pneumoniae</i> (Review). Mol Med Rep.
2016;14:4030&#x2010;4036. DOI: 10.3892/mmr.2016.5765

</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.5765</ArticleId><ArticleId IdType="pmc">PMC5101875</ArticleId><ArticleId IdType="pubmed">27667580</ArticleId></ArticleIdList></Reference><Reference><Citation>
Zhou H, Chen X, Li J. Effect of methylprednisolone plus azithromycin on fractional exhaled nitric oxide and peripheral blood eosinophils in children with refractory <i>Mycoplasma pneumoniae</i> pneumonia. J Coll Physicians Surg Pak.
2022;32:33&#x2010;36. DOI: 10.29271/jcpsp.2022.01.33

</Citation><ArticleIdList><ArticleId IdType="doi">10.29271/jcpsp.2022.01.33</ArticleId><ArticleId IdType="pubmed">34983144</ArticleId></ArticleIdList></Reference><Reference><Citation>
Sun LL, Ye C, Zhou YL, Zuo SR, Deng ZZ, Wang CJ. Meta&#x2010;analysis of the clinical efficacy and safety of high&#x2010; and low&#x2010;dose methylprednisolone in the treatment of children with severe <i>Mycoplasma pneumoniae</i> pneumonia. Pediatr Infect Dis J.
2020;39:177&#x2010;183. DOI: 10.1097/INF.0000000000002529

</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002529</ArticleId><ArticleId IdType="pubmed">31738328</ArticleId></ArticleIdList></Reference><Reference><Citation>
Qu X, Xu Z, Lin X. Effects of different doses of methylprednisolone on TNF&#x2010;&#x3b1;, IL&#x2010;6, and IL&#x2010;13 in serum and bronchoalveolar lavage fluid of children with severe <i>Mycoplasma pneumoniae</i> pneumonia. J Biol Regul Homeost Agents.
2020;34:1889&#x2010;1895. DOI: 10.23812/20-317-L

</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-317-L</ArticleId><ArticleId IdType="pubmed">32996302</ArticleId></ArticleIdList></Reference><Reference><Citation>
The Subspecialty Group of Respiratory
, the Society of Pediatrics
, Chinese Medical Association
, China National Clinical Research Center of Respiratory Diseases
, Editorial Board
, 
<i>Chinese Journal of Pediatrics</i>

. Evidence&#x2010;based guideline for the diagnosis and treatment of <i>Mycoplasma pneumoniae</i> pneumonia in children (2023). <i>Pediatr Investig</i>. 2025;9:1&#x2010;11. DOI: 10.1002/ped4.12469
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ped4.12469</ArticleId><ArticleId IdType="pmc">PMC11998179</ArticleId><ArticleId IdType="pubmed">40241891</ArticleId></ArticleIdList></Reference><Reference><Citation>
Tsai TA, Tsai CK, Kuo KC, Yu HR. Rational stepwise approach for <i>Mycoplasma pneumoniae</i> pneumonia in children. J Microbiol Immunol Infect.
2021;54:557&#x2010;565. DOI: 10.1016/j.jmii.2020.10.002

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.10.002</ArticleId><ArticleId IdType="pubmed">33268306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HS, Sol IS, Li D, Choi M, Choi YJ, Lee KS, et&#xa0;al. Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta&#x2010;analysis of randomized controlled trials. BMC Pulm Med. 2019;19:251. DOI: 10.1186/s12890-019-0990-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-019-0990-8</ArticleId><ArticleId IdType="pmc">PMC6921474</ArticleId><ArticleId IdType="pubmed">31852460</ArticleId></ArticleIdList></Reference><Reference><Citation>
You SY, Jwa HJ, Yang EA, Kil HR, Lee JH. Effects of methylprednisolone pulse therapy on refractory <i>Mycoplasma pneumoniae</i> pneumonia in children. Allergy Asthma Immunol Res.
2014;6:22&#x2010;26. DOI: 10.4168/aair.2014.6.1.22

</Citation><ArticleIdList><ArticleId IdType="doi">10.4168/aair.2014.6.1.22</ArticleId><ArticleId IdType="pmc">PMC3881395</ArticleId><ArticleId IdType="pubmed">24404389</ArticleId></ArticleIdList></Reference><Reference><Citation>
Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T. Methylprednisolone pulse therapy for refractory <i>Mycoplasma pneumoniae</i> pneumonia in children. J Infect.
2008;57:223&#x2010;228. DOI: 10.1016/j.jinf.2008.06.012

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2008.06.012</ArticleId><ArticleId IdType="pmc">PMC7112643</ArticleId><ArticleId IdType="pubmed">18656264</ArticleId></ArticleIdList></Reference><Reference><Citation>
Xu B, Peng X, Yao Y, Yin J, Chen L, Liu J, et&#xa0;al. Low&#x2010;dose versus high&#x2010;dose methylprednisolone for children with severe <i>Mycoplasma pneumoniae</i> pneumonia (MCMP): study protocol for a randomized controlled trial. Pediatr Investig.
2018;2:176&#x2010;183. DOI: 10.1002/ped4.12041
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ped4.12041</ArticleId><ArticleId IdType="pmc">PMC7331410</ArticleId><ArticleId IdType="pubmed">32851257</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley &amp; Sons; 1987.</Citation></Reference><Reference><Citation>
Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. 
<i>Mycoplasma pneumoniae</i> from the respiratory tract and beyond. Clin Microbiol Rev.
2017;30:747&#x2010;809. DOI: 10.1128/CMR.00114-16

</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00114-16</ArticleId><ArticleId IdType="pmc">PMC5475226</ArticleId><ArticleId IdType="pubmed">28539503</ArticleId></ArticleIdList></Reference><Reference><Citation>
Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z. The clinical characteristics and predictors of refractory <i>Mycoplasma pneumoniae</i> pneumonia in children. PLoS One.
2016;11:e0156465. DOI: 10.1371/journal.pone.0156465

</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0156465</ArticleId><ArticleId IdType="pmc">PMC4882022</ArticleId><ArticleId IdType="pubmed">27227519</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui DS, Lodge CJ, Burgess JA, Lowe AJ, Perret J, Bui MQ, et&#xa0;al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med. 2018;6:535&#x2010;544. DOI: 10.1016/S2213-2600(18)30100-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30100-0</ArticleId><ArticleId IdType="pubmed">29628376</ArticleId></ArticleIdList></Reference><Reference><Citation>
Okumura T, Kawada JI, Tanaka M, Narita K, Ishiguro T, Hirayama Y, et&#xa0;al. Comparison of high&#x2010;dose and low&#x2010;dose corticosteroid therapy for refractory <i>Mycoplasma pneumoniae</i> pneumonia in children. J Infect Chemother.
2019;25:346&#x2010;350. DOI: 10.1016/j.jiac.2019.01.003

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2019.01.003</ArticleId><ArticleId IdType="pubmed">30718192</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, van Velzen&#x2010;Blad H, et&#xa0;al. Dexamethasone and length of hospital stay in patients with community&#x2010;acquired pneumonia: a randomised, double&#x2010;blind, placebo&#x2010;controlled trial. Lancet. 2011;377:2023&#x2010;2030. DOI: 10.1016/S0140-6736(11)60607-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60607-7</ArticleId><ArticleId IdType="pubmed">21636122</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri GU, Shih MC, Bridges L, Martin TJ, El&#x2010;Solh A, Seam N, et&#xa0;al. Low&#x2010;dose methylprednisolone treatment in critically ill patients with severe community&#x2010;acquired pneumonia. Intensive Care Med. 2022;48:1009&#x2010;1023. DOI: 10.1007/s00134-022-06684-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-022-06684-3</ArticleId><ArticleId IdType="pmc">PMC9208259</ArticleId><ArticleId IdType="pubmed">35723686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirracchio R, Venkatesh B, Legrand M. Low&#x2010;dose corticosteroids for critically ill adults with severe pulmonary infections: a Review. JAMA. 2024;332:318&#x2010;328. DOI: 10.1001/jama.2024.6096</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2024.6096</ArticleId><ArticleId IdType="pubmed">38865154</ArticleId></ArticleIdList></Reference><Reference><Citation>
The Subspecialty Group of Respiratory
, the Society of Pediatrics
, Chinese Medical Association; Editorial Board
, 
<i>Chinese Journal of Pediatrics</i>; China Medicine Education Association Committee on Pediatrics
. Guidelines for the management of community&#x2010;acquired pneumonia in children (2024 revision) (In Chinese). Chin J Pediatr.
2024;62:920&#x2010;930. DOI: 10.3760/cma.j.cn112140-20240728-00523
</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.cn112140-20240728-00523</ArticleId><ArticleId IdType="pubmed">39327958</ArticleId></ArticleIdList></Reference><Reference><Citation>
Li Y, Wu M, Liang Y, Yang Y, Guo W, Deng Y, et&#xa0;al. 
<i>Mycoplasma pneumoniae</i> infection outbreak in Guangzhou, China after COVID&#x2010;19 pandemic. Virol J.
2024;21:183. DOI: 10.1186/s12985-024-02458-z

</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-024-02458-z</ArticleId><ArticleId IdType="pmc">PMC11318190</ArticleId><ArticleId IdType="pubmed">39129001</ArticleId></ArticleIdList></Reference><Reference><Citation>
Yuan C, Min FM, Ling YJ, Li G, Ye HZ, Pan JH, et&#xa0;al. Clinical characteristics and antibiotic resistance of <i>Mycoplasma pneumoniae</i> pneumonia in hospitalized Chinese children. Comb Chem High Throughput Screen.
2018;21:749&#x2010;754. DOI: 10.2174/1386207322666190111112946

</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1386207322666190111112946</ArticleId><ArticleId IdType="pubmed">30636596</ArticleId></ArticleIdList></Reference><Reference><Citation>
Chen YC, Hsu WY, Chang TH. Macrolide&#x2010;resistant <i>Mycoplasma pneumoniae</i> infections in pediatric community&#x2010;acquired pneumonia. Emerg Infect Dis.
2020;26:1382&#x2010;1391. DOI: 10.3201/eid2607.200017

</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2607.200017</ArticleId><ArticleId IdType="pmc">PMC7323531</ArticleId><ArticleId IdType="pubmed">32568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan YD, Sun TW, Liu ZQ, Zhang SG, Wang LX, Kan QC. Efficacy and safety of corticosteroids for community&#x2010;acquired pneumonia: a systematic review and meta&#x2010;analysis. Chest. 2016;149:209&#x2010;219. DOI: 10.1378/chest.15-1733</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.15-1733</ArticleId><ArticleId IdType="pubmed">26501852</ArticleId></ArticleIdList></Reference><Reference><Citation>Dequin PF, Meziani F, Quenot JP, Kamel T, Ricard JD, Badie J, et&#xa0;al. Hydrocortisone in severe community&#x2010;acquired pneumonia. N Engl J Med. 2023;388:1931&#x2010;1941. DOI: 10.1056/NEJMoa2215145</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2215145</ArticleId><ArticleId IdType="pubmed">36942789</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>